Enhancement of T cell recruitment and infiltration into tumours

Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer

(2013) D. Alizadeh et al.   CANCER RESEARCH

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

(2013) Tyler R. Simpson et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

(2013) Rikke B. Holmgaard et al.   JOURNAL OF EXPERIMENTAL MEDICINE

T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy

(2013) Feng Yu et al.   MOLECULAR THERAPY

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

(2013) Christel Devaud et al.   OncoImmunology

Effects of conventional therapeutic interventions on the number and function of regulatory T cells

(2013) Mario Roselli et al.   OncoImmunology

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer

(2012) A Popple et al.   BRITISH JOURNAL OF CANCER

T-Cell Trafficking Facilitated by High Endothelial Venules Is Required for Tumor Control after Regulatory T-Cell Depletion

(2012) J. P. Hindley et al.   CANCER RESEARCH

PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-  Inducible Chemokines

(2012) W. Peng et al.   CANCER RESEARCH

BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice

(2012) C. Liu et al.   CLINICAL CANCER RESEARCH

CTLA-4 Blockade Expands Infiltrating T Cells and Inhibits Cancer Cell Repopulation during the Intervals of Chemotherapy in Murine Mesothelioma

(2012) L. Wu et al.   MOLECULAR CANCER THERAPEUTICS

Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine

(2012) Chantal G Lemay et al.   MOLECULAR THERAPY

Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells

(2012) Vivian L. Weiss et al.   PLoS One

Combined targeted therapy and immunotherapy in the treatment of advanced melanoma

(2012) James S. Wilmott et al.   OncoImmunology

Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control

(2011) M. Hong et al.   CANCER RESEARCH

Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy

(2011) R. Waitz et al.   CANCER RESEARCH

Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer

(2011) L. Martinet et al.   CANCER RESEARCH

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

(2011) R. R. Huang et al.   CLINICAL CANCER RESEARCH

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma

(2011) Valerie Chew et al.   GUT

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells

(2011) Barbara Molon et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions

(2011) Alessandra Nardin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor

(2011) Anna M Dahlin et al.   MODERN PATHOLOGY

Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer

(2010) R. K. Shrimali et al.   CANCER RESEARCH

Efficient Treg depletion induces T-cell infiltration and rejection of large tumors

(2010) Xingrui Li et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Memory T-cell trafficking: new directions for busy commuters

(2010) Federica M. Marelli-Berg et al.   IMMUNOLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation of CXCL12 Expression and FoxP3 + Cell Infiltration with Human Papillomavirus Infection and Clinicopathological Progression of Cervical Cancer

(2009) Fatimah Jaafar et al.   AMERICAN JOURNAL OF PATHOLOGY

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

(2009) H. Harlin et al.   CANCER RESEARCH

Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions

(2009) Jennifer K. Mulligan et al.   HUMAN IMMUNOLOGY

Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response

(2009) Nan Soon Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer

(2008) N Yoshitake et al.   BRITISH JOURNAL OF CANCER

Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors

(2008) Carl C Schimanski et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The highway code of T cell trafficking

(2007) FM Marelli-Berg et al.   JOURNAL OF PATHOLOGY